181 related articles for article (PubMed ID: 18221230)
1. Rho-ROCK inhibitors for the treatment of CNS injury.
Kubo T; Yamashita T
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):173-9. PubMed ID: 18221230
[TBL] [Abstract][Full Text] [Related]
2. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
Kubo T; Hata K; Yamaguchi A; Yamashita T
Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.
Kubo T; Yamaguchi A; Iwata N; Yamashita T
Ther Clin Risk Manag; 2008 Jun; 4(3):605-15. PubMed ID: 18827856
[TBL] [Abstract][Full Text] [Related]
4. Axon growth inhibition by RhoA/ROCK in the central nervous system.
Fujita Y; Yamashita T
Front Neurosci; 2014; 8():338. PubMed ID: 25374504
[TBL] [Abstract][Full Text] [Related]
5. Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling.
Roloff F; Scheiblich H; Dewitz C; Dempewolf S; Stern M; Bicker G
PLoS One; 2015; 10(2):e0118536. PubMed ID: 25714396
[TBL] [Abstract][Full Text] [Related]
6. Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.
Tan HB; Zhong YS; Cheng Y; Shen X
Int J Ophthalmol; 2011; 4(6):652-7. PubMed ID: 22553739
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism and regulation of axon growth inhibition].
Yamashita T
Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase inhibition enhances axonal regeneration in the injured CNS.
Fournier AE; Takizawa BT; Strittmatter SM
J Neurosci; 2003 Feb; 23(4):1416-23. PubMed ID: 12598630
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo.
Lingor P; Teusch N; Schwarz K; Mueller R; Mack H; Bähr M; Mueller BK
J Neurochem; 2007 Oct; 103(1):181-9. PubMed ID: 17608642
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
Walmsley AR; Mir AK
Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
[TBL] [Abstract][Full Text] [Related]
11. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells.
Lingor P; Tönges L; Pieper N; Bermel C; Barski E; Planchamp V; Bähr M
Brain; 2008 Jan; 131(Pt 1):250-63. PubMed ID: 18063589
[TBL] [Abstract][Full Text] [Related]
12. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1.
Niederöst B; Oertle T; Fritsche J; McKinney RA; Bandtlow CE
J Neurosci; 2002 Dec; 22(23):10368-76. PubMed ID: 12451136
[TBL] [Abstract][Full Text] [Related]
13. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury.
Holmberg E; Nordstrom T; Gross M; Kluge B; Zhang SX; Doolen S
J Neurotrauma; 2006 Sep; 23(9):1366-78. PubMed ID: 16958588
[TBL] [Abstract][Full Text] [Related]
15. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition.
Alabed YZ; Pool M; Ong Tone S; Fournier AE
J Neurosci; 2007 Feb; 27(7):1702-11. PubMed ID: 17301178
[TBL] [Abstract][Full Text] [Related]
16. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
Deng Q; Cai W; Li S; Zhang Y; Su B
Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
[TBL] [Abstract][Full Text] [Related]
17. Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.
Yang P; Wen HZ; Zhang JH
Acta Pharmacol Sin; 2010 May; 31(5):531-9. PubMed ID: 20383168
[TBL] [Abstract][Full Text] [Related]
18. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
[TBL] [Abstract][Full Text] [Related]
19. The development of a rat in vitro model of spinal cord injury demonstrating the additive effects of Rho and ROCK inhibitors on neurite outgrowth and myelination.
Boomkamp SD; Riehle MO; Wood J; Olson MF; Barnett SC
Glia; 2012 Mar; 60(3):441-56. PubMed ID: 22139636
[TBL] [Abstract][Full Text] [Related]
20. Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation.
Chambel SS; Cruz CD
Neural Regen Res; 2023 Dec; 18(12):2573-2581. PubMed ID: 37449592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]